Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ami Lifesciences manufactures and supplies over forty-eight commercial active pharmaceutical ingredients across ten therapeutic categories. The company’s APIs are used globally by leading pharmaceutical companies and have regulatory approvals such as USDMF, CEPs, KDMFs and others. No clinical trial results are reported as the company does not develop finished drugs but supplies APIs for further formulation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ami Lifesciences.